MAM
FLNA

Martingale Asset Management’s Filana Therapeutics FLNA Stock Holding History

Martingale Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,747
Closed -$262K – 841
2023
Q3 		$262K Hold
15,747
– – 0.01% 710
2023
Q2 		$386K Buy
+15,747
New +$379K 0.01% 659

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Martingale Asset Management's FLNA Position: Q4 2023 in Review

Martingale Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2023, closing a stake of 15,747 shares — an estimated $262K sold.

Martingale Asset Management first reported a position in FLNA in Q2 2023 and held it in 2 quarters. The position peaked at $386K in Q2 2023. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2023.

  • Martingale Asset Management reported no remaining Filana Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Martingale Asset Management sold 15,747 Filana Therapeutics shares in Q4 2023, an estimated $262K.
  • Martingale Asset Management first reported a position in Filana Therapeutics in Q2 2023 and held it in 2 quarters.
  • Martingale Asset Management's Filana Therapeutics position peaked at $386K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2023.

Based on Martingale Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.